An improved protocol to establish experimental tuberculous meningitis in the rabbit

by Paul O'Brien, Christopher Vinnard, Selvakumar Subbian
Published 2020-01-01

Isoniazid Toxicity among an Older Veteran Population: A Retrospective Cohort Study

by Christopher Vinnard, Anand Gopal, Darren R. Linkin, Joel Maslow
Published 2013-01-01

Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model

by Ranjeet Kumar, Afsal Kolloli, Pooja Singh, Christopher Vinnard, Gilla Kaplan, Selvakumar Subbian
Published 2020-01-01

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis

by Alyssa Mezochow, Kiran T. Thakur, Isaac Zentner, Selvakumar Subbian, Leonid Kagan, Christopher Vinnard
Published 2019-07-01

Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

by Christopher Vinnard, Alyssa Mezochow, Hannah Oakland, Ross Klingsberg, John Hansen-Flaschen, Keith Hamilton
Published 2018-11-01

Isoniazid-Resistant Tuberculous Meningitis, United States, 1993–2005

by Christopher Vinnard, Carla A. Winston, E. Paul Wileyto, Rob Roy MacGregor, Gregory P. Bisson
Published 2011-03-01

Adipose Tissue Regulates Pulmonary Pathology during TB Infection

by Janeesh Plakkal Ayyappan, Usha Ganapathi, Kezia Lizardo, Christopher Vinnard, Selvakumar Subbian, David Perlin, Jyothi F. Nagajyothi
Published 2019-04-01

A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short Report

by Christopher Vinnard, Isabel Manley, Brittney Scott, Mariana Bernui, Joella Adams, Sheryl Varghese, Isaac Zentner, Michele A. Kutzler
Published 2017-01-01

Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease

by Aashka Parikh, Christopher Vinnard, Nicole Fahrenfeld, Amy L. Davidow, Amee Patrawalla, Alfred Lardizabal, Andrew Gow, Reynold Panettieri, Maria Gennaro
Published 2019-11-01

Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States

by José R. Mediavilla, Amee Patrawalla, Liang Chen, Kalyan D. Chavda, Barun Mathema, Christopher Vinnard, Lisa L. Dever, Barry N. Kreiswirth
Published 2016-08-01

Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study

by Isaac Zentner, Hyun-moon Back, Leonid Kagan, Selvakumar Subbian, Jyothi Nagajyothi, Shashikant Srivastava, Jotam Pasipanodya, Tawanda Gumbo, Gregory P. Bisson, Christopher Vinnard
Published 2020-07-01

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

by Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M Zetola, Drew Weissman, Tawanda Gumbo, Gregory P Bisson
Published 2017-01-01

Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment

by Isaac Zentner, Chawangwa Modongo, Nicola M. Zetola, Jotam G. Pasipanodya, Shashikant Srivastava, Scott K. Heysell, Stellah Mpagama, Hans P. Schlect, Tawanda Gumbo, Gregory P. Bisson, Christopher Vinnard
Published 2018-03-01